Exploring the effect of Silymarin on generalized hypoxia-induced liver damage

Phase 2

Recruiting

• Conditions: Hypoxia.; Acute respiratory failure with hypoxia; J96.01

• Registration Number: IRCT20141209020258N112
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 August 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

Hypoxia patients
Age older than 18 years

Exclusion Criteria

Death of the patient
Dissatisfaction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
iver enzymes (ALT,AST? CPK). Timepoint: Before and after treatment. Method of measurement: Blood test.;White blood cell count. Timepoint: Before and after treatment. Method of measurement: Blood test.;Coagulation factors (PT? PTT? INR ). Timepoint: Before and after treatment. Method of measurement: Blood test.